drugset / Trial / NCT03469531
Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this phase II trial is to determine the feasibility and efficacy of nimotuzumab combined with concurrent chemoradiotherapy for initially inoperable locally advanced cervical squamous cell carcinoma.
Timeline
- Start
- 2018-03-20
- Primary completion
- 2021-03-10
- Completion
- 2021-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nimotuzumab | Monoclonal antibody | — | Intravenous |
| Background | Cisplatin | Other / unclassified | 25 mg/m2 | — |
| Background | Cisplatin | Other / unclassified | 40 mg/m2 | — |